This brand name is authorized in Nigeria.
The drug CILZEC PLUS contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
U5SYW473RQ - TELMISARTAN
|
Telmisartan is an orally active and specific angiotensin II receptor (type AT1) antagonist. Telmisartan selectively binds the AT1 receptor. The binding is long-lasting. |
|
2
|
UNII
0J48LPH2TH - HYDROCHLOROTHIAZIDE
|
Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted. |
|
This drug has been approved in Nigeria as follows:
Identifier | Form | Presentation | Description | Approval |
---|---|---|---|---|
A4-6823 | Tablet | CILZEC PLUS TABLETS 40/12.5 TAB 40 mg; 12.5 mg 3x10 | 92 RNW-PP-263329 CILZEC PLUS TABLETS 40/12.5 TELMISARTAN USP 40MG, HYDROCHLOROTHIAZIDE USP 12.5MG TELMISARTAN USP 40MG, HYDROCHLOROTHIAZIDE USP 12.5MG, TELMISARTAN LAYER: MEGLUMIN 10MG, SODIUM HYDROXIDE 3.25MG, POVIDONE 7MG, POLYSORBATE 80 0.75MG, MANNITOL 203MG, PURIFIED WATER Q.S, MAGNESIUM STEARATE 5.8MG, HYDROCHLOROTHIAZIDE LAYER: LACTOSE MONOHYDRATE 79MG, MICROCRYSTALLINE CELLULOSE 91MG, LAKE SUNSET YELLOW 1MG, POVIDONE 3MG, PURIFIED WATER Q.S., SODIUM STARCH GLYCOLATE 12MG, MAGNESIUM STEARATE 1.5MG. A4-6823 Drugs CARDIOVASCULAR SYSTEM Imported Products 310 Prescription Only Medicine (POM) 5/9/2022 MEGA LIFESCIENCES NIGERIA LIMITED, GUINNESS ROAD, OGBA - IKEJA OGBA LAGOS 8053596201 info.ng@megawecare.com MSN LABORATORIES PRIVATE LIMITED, Plot No.42, Anrich Industrial Estate, Bollaram, Sangareddy District, Telangana, Pincode - 502325, India, India | 28/03/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC Group | Classification | |
---|---|---|
C09DA07 | Telmisartan and diuretics | C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DA Angiotensin II antagonists and diuretics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
NG | Registered Drug Product Database | A4-6823 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.